X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11917) 11917
Newsletter (239) 239
Book Chapter (121) 121
Magazine Article (30) 30
Newspaper Article (30) 30
Book / eBook (23) 23
Publication (6) 6
Book Review (4) 4
Journal / eJournal (2) 2
Reference (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9821) 9821
vasculitis (6082) 6082
female (5317) 5317
male (4898) 4898
index medicus (4888) 4888
middle aged (3588) 3588
adult (3539) 3539
rheumatology (2704) 2704
aged (2401) 2401
treatment outcome (1877) 1877
immunosuppressive agents - therapeutic use (1759) 1759
vasculitis - drug therapy (1724) 1724
diagnosis, differential (1154) 1154
disease (1153) 1153
medicine & public health (1092) 1092
diagnosis (1081) 1081
therapy (1079) 1079
medicine, general & internal (1034) 1034
adolescent (1030) 1030
biopsy (996) 996
rituximab (947) 947
drug therapy, combination (941) 941
care and treatment (903) 903
cyclophosphamide - therapeutic use (901) 901
vasculitis - diagnosis (877) 877
retrospective studies (871) 871
immunology (869) 869
vasculitis - complications (838) 838
glucocorticoids - therapeutic use (837) 837
vasculitis - pathology (830) 830
cyclophosphamide (829) 829
risk factors (820) 820
child (797) 797
wegeners-granulomatosis (795) 795
systemic vasculitis (790) 790
dermatology (774) 774
vasculitis - immunology (736) 736
prognosis (734) 734
inflammation (710) 710
vasculitis - etiology (703) 703
animals (686) 686
research (683) 683
patients (682) 682
urology & nephrology (651) 651
follow-up studies (615) 615
magnetic resonance imaging (602) 602
microscopic polyangiitis (600) 600
anca-associated vasculitis (596) 596
adrenal cortex hormones - therapeutic use (586) 586
health aspects (586) 586
aged, 80 and over (577) 577
antineutrophil cytoplasmic antibodies (575) 575
young adult (569) 569
autoantibodies (566) 566
recurrence (566) 566
systemic lupus erythematosus (566) 566
glomerulonephritis (564) 564
anti-inflammatory agents - therapeutic use (553) 553
abridged index medicus (552) 552
clinical neurology (547) 547
ophthalmology (547) 547
anca (539) 539
classification (531) 531
granulomatosis with polyangiitis - drug therapy (527) 527
drug therapy (525) 525
antibodies, antineutrophil cytoplasmic - blood (524) 524
arthritis (521) 521
internal medicine (513) 513
antibodies (512) 512
prednisone - therapeutic use (493) 493
anti-neutrophil cytoplasmic antibody-associated vasculitis - drug therapy (490) 490
children (489) 489
corticosteroids (488) 488
rheumatoid arthritis (487) 487
prednisolone - therapeutic use (478) 478
pediatrics (474) 474
severity of illness index (470) 470
lupus (462) 462
remission induction (457) 457
churg-strauss-syndrome (439) 439
medical research (428) 428
case report (422) 422
systemic-lupus-erythematosus (414) 414
analysis (408) 408
rheumatoid-arthritis (405) 405
tomography, x-ray computed (399) 399
polyarteritis-nodosa (397) 397
wegener's granulomatosis (396) 396
time factors (385) 385
vasculitis - therapy (385) 385
vasculitis - chemically induced (383) 383
autoimmune diseases (374) 374
skin - pathology (374) 374
mortality (373) 373
medicine (365) 365
antibodies, antineutrophil cytoplasmic - immunology (362) 362
patient (358) 358
antibody-associated vasculitis (357) 357
manifestations (357) 357
remission (357) 357
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11348) 11348
French (295) 295
German (294) 294
Spanish (151) 151
Japanese (150) 150
Russian (51) 51
Italian (33) 33
Polish (29) 29
Chinese (21) 21
Portuguese (18) 18
Danish (15) 15
Dutch (14) 14
Romanian (10) 10
Hungarian (9) 9
Swedish (7) 7
Turkish (7) 7
Finnish (6) 6
Korean (6) 6
Norwegian (6) 6
Hebrew (5) 5
Serbian (4) 4
Croatian (3) 3
Arabic (2) 2
Czech (2) 2
Slovak (2) 2
Ukrainian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 8, pp. 2052 - 2062.e2
...–induced cryoglobulinemia vasculitis (HCV-CV). We analyzed blood samples from patients with HCV-CV before and after DAA therapy to determine mechanisms of these drugs and their effects on cellular immunity... 
Gastroenterology and Hepatology | Immune Regulation | PDCD1 | Response To Treatment | Liver Disease | BAFF | ENVELOPE PROTEIN | RANDOMIZED CONTROLLED-TRIAL | MIXED CRYOGLOBULINEMIA | DEFICIENCY | AUTOIMMUNITY | RITUXIMAB | EXPANSION | REGULATORY T-CELL | GASTROENTEROLOGY & HEPATOLOGY | LYMPHOCYTES | T-Lymphocyte Subsets - immunology | Prospective Studies | Hepatitis C - drug therapy | Humans | Middle Aged | Cryoglobulinemia - diagnosis | Male | Vasculitis - virology | Cryoglobulinemia - virology | Hepatitis Viruses - drug effects | Simeprevir - therapeutic use | Case-Control Studies | Simeprevir - adverse effects | Viral Load | Vasculitis - immunology | Hepatitis C - immunology | Immunity, Cellular - drug effects | Time Factors | T-Lymphocyte Subsets - drug effects | B-Lymphocyte Subsets - immunology | Female | Hepatitis C - complications | Imidazoles - therapeutic use | Sofosbuvir - adverse effects | Drug Therapy, Combination | B-Lymphocyte Subsets - virology | Cytokines - blood | Immune Tolerance - drug effects | Sofosbuvir - therapeutic use | B-Lymphocyte Subsets - drug effects | Antiviral Agents - therapeutic use | Hepatitis Viruses - immunology | Cryoglobulinemia - drug therapy | Imidazoles - adverse effects | Ribavirin - therapeutic use | Treatment Outcome | Biomarkers - blood | T-Lymphocyte Subsets - virology | Cryoglobulinemia - immunology | Hepatitis C - diagnosis | Phenotype | B-Lymphocyte Subsets - metabolism | Vasculitis - diagnosis | Ribavirin - adverse effects | T-Lymphocyte Subsets - metabolism | Antiviral Agents - adverse effects | Vasculitis - drug therapy | Aged | Care and treatment | Vasculitis | Analysis | Gastrointestinal diseases | Interferon | Biological response modifiers | Hepatitis C virus | Antiviral agents | Medical research | Liver | Medicine, Experimental | Life Sciences | Immunology
Journal Article
CONTINUUM: Lifelong Learning in Neurology, ISSN 1080-2371, 12/2012, Volume 18, Issue 6, Infectious Disease, pp. 1290 - 1318
Purpose of ReviewThis article describes the background, clinical presentation, diagnosis, and treatment of selected etiologies of subacute and chronic... 
Meningitis, Cryptococcal - drug therapy | Tuberculosis, Meningeal - diagnosis | Humans | Meningitis, Fungal - microbiology | Middle Aged | Neuroaspergillosis - diagnosis | Male | Meningitis - etiology | Antifungal Agents - therapeutic use | Meningitis, Fungal - drug therapy | Meningitis - drug therapy | Neurosyphilis - diagnosis | Blastomycosis - diagnosis | Blastomycosis - drug therapy | Vasculitis, Central Nervous System - diagnosis | Fatal Outcome | Lupus Erythematosus, Systemic - drug therapy | Meningitis - diagnosis | Histoplasmosis - diagnosis | Adult | Female | Coccidioidomycosis - drug therapy | Meningitis, Bacterial - drug therapy | Sarcoidosis - diagnosis | Acute Disease | Meningeal Carcinomatosis - drug therapy | Meningitis, Bacterial - microbiology | Vasculitis, Central Nervous System - drug therapy | Meningeal Carcinomatosis - diagnosis | Tuberculosis, Meningeal - drug therapy | Meningitis, Bacterial - diagnosis | Early Detection of Cancer | Sarcoidosis - drug therapy | Behcet Syndrome - drug therapy | Neuroaspergillosis - drug therapy | Meningitis, Cryptococcal - diagnosis | Coccidioidomycosis - diagnosis | Lupus Erythematosus, Systemic - diagnosis | Mycobacterium tuberculosis | Central Nervous System Diseases - drug therapy | Behcet Syndrome - diagnosis | Central Nervous System Diseases - diagnosis | Histoplasmosis - drug therapy | Meningitis, Fungal - diagnosis | Neurosyphilis - drug therapy | Chronic Disease
Journal Article
Journal of bone and mineral research, ISSN 1523-4681, 2015, Volume 30, Issue 9, pp. 1667 - 1675
... patients with rheumatic disorders, glucocorticoids (GC) continue to be an important treatment for many patients. At the same time, GC therapy is associated... 
GLUCOCORTICOIDS | BONE DENSITY | VERTEBRAL FRACTURES | RHEUMATIC DISORDERS | ADOLESCENTS | CHILDREN | rheumatic disorders | glucocorticoids | adolescents | children | vertebral fractures | bone density | INDUCED OSTEOPOROSIS | SYSTEMIC-LUPUS-ERYTHEMATOSUS | BONE HEALTH | JUVENILE IDIOPATHIC ARTHRITIS | DISEASE-ACTIVITY | THERAPY | GROWTH | ENDOCRINOLOGY & METABOLISM | COMPRESSION FRACTURES | Glucocorticoids - therapeutic use | Lupus Erythematosus, Systemic - complications | Rheumatic Diseases - drug therapy | Scleroderma, Localized - complications | Humans | Male | Osteoporosis - drug therapy | Dermatomyositis - complications | Arthritis, Juvenile - drug therapy | Incidence | Systemic Vasculitis - complications | Dermatomyositis - drug therapy | Scleroderma, Systemic - complications | Lupus Erythematosus, Systemic - drug therapy | Female | Child | Glucocorticoids - adverse effects | Spinal Fractures - diagnosis | Scleroderma, Localized - drug therapy | Bone Density | Risk Factors | Proportional Hazards Models | Spinal Fractures - epidemiology | Systemic Vasculitis - drug therapy | Spinal Fractures - chemically induced | Adolescent | Arthritis, Juvenile - complications | Rheumatic Diseases - complications | Scleroderma, Systemic - drug therapy | Cohort Studies | Pediatrics | Fractures | Corticosteroids | Bones | Children | Health aspects | Density | Risk factors | Steroids | Vertebrae | Glucocorticoids | Spine (lumbar) | Prednisone | Patients | Radiography | Osteoporosis | Body mass index | Bone mineral density
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2005, Volume 64, Issue 6, pp. 913 - 920
Journal Article
Neurology, ISSN 0028-3878, 06/2018, Volume 91, Issue 4, pp. E359 - E363
OBJECTIVETo report on 2 women with multiple sclerosis (MS) who developed severe neurologic deterioration and a drug reaction with eosinophilia and systemic symptoms (DRESS... 
CNS | REMITTING MULTIPLE-SCLEROSIS | VASCULITIS | CLINICAL NEUROLOGY
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2006, Volume 12, Issue 17, pp. 5165 - 5173
...) received everolimus. No dose-limiting toxicities were observed. Grade 3 potentially drug-related toxicities... 
mTOR inhibitor | 4E-BP1 | hypoxia-inducible factor | chronic lymphocytic leukemia | p70S6K | myelodysplastic syndrome | WORKING GROUP | PHARMACOKINETICS | ONCOLOGY | CYCLIN D1 | PATHWAY | OBLITERANS ORGANIZING PNEUMONIA | TEMSIROLIMUS CCI-779 | DOWN-REGULATION | AKT | MTOR INHIBITORS | CANCER | Protein Kinases - metabolism | Recurrence | Phosphorylation | Humans | Leukemia, Prolymphocytic - drug therapy | Middle Aged | Leukemia, T-Cell - drug therapy | Vasculitis, Leukocytoclastic, Cutaneous - chemically induced | Male | Phosphoproteins - antagonists & inhibitors | Dose-Response Relationship, Drug | Adaptor Proteins, Signal Transducing - antagonists & inhibitors | Drug-Related Side Effects and Adverse Reactions | Killer Cells, Natural - immunology | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Everolimus | Myelodysplastic Syndromes - drug therapy | Sirolimus - adverse effects | Protein Kinases - drug effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Drug Administration Schedule | Administration, Oral | Ribosomal Protein S6 Kinases, 70-kDa - antagonists & inhibitors | Lymphoma, Mantle-Cell - drug therapy | Treatment Outcome | Sirolimus - administration & dosage | Maximum Tolerated Dose | Signal Transduction - drug effects | Adolescent | T-Lymphocytes - immunology | Aged | TOR Serine-Threonine Kinases | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 11/2012, Volume 126, Issue 21, pp. 2473 - 2480
Journal Article
Current Opinion in Rheumatology, ISSN 1040-8711, 01/2016, Volume 28, Issue 1, pp. 15 - 20
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0332, 2015, Volume 54, Issue 7, pp. 1153 - 1160
.... The aim of this study was to explore the long-term outcomes of AAV patients treated with repeat-dose RTX maintenance therapy. Methods... 
Biologic therapies | Microscopic polyangiitis | Vasculitis | Maintenance treatment | Granulomatosis with polyangiitis | B cells | Anti-neutrophil cytoplasm antibody | granulomatosis with polyangiitis | biologic therapies | microscopic polyangiitis | vasculitis | anti-neutrophil cytoplasm antibody | maintenance treatment | WEGENERS-GRANULOMATOSIS | RHEUMATOID-ARTHRITIS | ANTIBODY-ASSOCIATED VASCULITIS | MANAGEMENT | CYCLOPHOSPHAMIDE | DEPLETION | PERIPHERAL-BLOOD | POLYMORPHISM | RHEUMATOLOGY | B-CELLS | REMISSION-INDUCTION | Recurrence | Prednisolone - administration & dosage | Follow-Up Studies | Antirheumatic Agents - administration & dosage | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Incidence | Dose-Response Relationship, Drug | Time Factors | Antirheumatic Agents - adverse effects | Adult | Female | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Immunosuppressive Agents - administration & dosage | Antirheumatic Agents - therapeutic use | Drug Administration Schedule | Rituximab | Treatment Outcome | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Antibodies, Monoclonal, Murine-Derived - adverse effects | Longitudinal Studies | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Cohort Studies | Clinical Science
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2010, Volume 363, Issue 3, pp. 211 - 220
A standard glucocorticoid regimen plus rituximab was not superior to standard intravenous cyclophosphamide as induction therapy in patients with newly diagnosed antineutrophil cytoplasmic antibody (ANCA... 
WEGENERS-GRANULOMATOSIS | MEDICINE, GENERAL & INTERNAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | MULTICENTER | ANTIBODY-ASSOCIATED VASCULITIS | THERAPY | EFFICACY | ACTIVE RHEUMATOID-ARTHRITIS | DOUBLE-BLIND | RANDOMIZED-TRIAL | REMISSION | Glucocorticoids - therapeutic use | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Methylprednisolone - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Incidence | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - mortality | Female | Drug Therapy, Combination | Glucocorticoids - adverse effects | Antibodies, Monoclonal, Murine-Derived | Glomerular Filtration Rate | Kidney Diseases - drug therapy | Rituximab | Kidney Diseases - mortality | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | B-Lymphocytes - drug effects | Intention to Treat Analysis | Immunosuppressive Agents - adverse effects | Aged | Infusions, Intravenous | Cyclophosphamide | Vasculitis | Research | Comparative analysis | Drug therapy | Clinical trials | Medical treatment | Mortality | Regulatory approval | Urologi och njurmedicin | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Urology and Nephrology
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2010, Volume 363, Issue 3, pp. 221 - 232
...−associated vasculitis. Rituximab therapy was not inferior to daily cyclophosphamide treatment for remission induction in severe